Congratulations to Neurology’s February 2025 SAFE accolade recipients
Congratulations to the members of the Department of Neurology who received accolades through the Supporting a Fair Environment (SAFE) program! SAFE aims to improve the learning environment by promoting positive behaviors and managing concerns about learner mistreatment and unprofessional behaviors. SAFE accolades include treating others with dignity and respect, creating an environment that values diversity, […]
$4.5 million supports pathbreaking neuroimmunology research (Links to an external site)
Washington University School of Medicine in St. Louis has received a three-year, $4.5 million grant from the Carol and Gene Ludwig Family Foundation, aimed at advancing research on neuroimmunology and neurodegeneration with the ultimate goal of developing new treatments for Alzheimer’s disease. Administered by WashU Medicine’s Brain Immunology & Glia (BIG) Center, the Carol and […]
Dai joins Adult Neurology Residency Program leadership
Xing “Cathy” Dai, MD, is the newest member of the Adult Neurology Residency Program leadership team at Washington University School of Medicine in St. Louis. She will join Salim Chahin, MD, MSCE, Renee Van Stavern, MD, and Gregory Wu, MD, PhD, as an associate program director, starting July 1, 2025. She began transitioning into the […]
Electrochemical field key to how dementia precursors ‘break bad’ (Links to an external site)
Protein accumulations do important work in the human body, but something can go wrong and proliferate in those aggregates, resulting in neurodegeneration and diseases such as Parkinson’s and Alzheimer’s. One such assembly, amyloid beta peptide, is synonymous with dementia, but researchers were not certain how these peptide assemblies “break bad” and what really causes them […]
Novel Gene Therapy Clinical Trial Targets Rett Syndrome
Washington University School of Medicine in St. Louis is one of only ten sites in the world participating in a pioneering clinical trial evaluating TSHA-102, an investigational gene therapy for the treatment of Rett syndrome, a severe neurodevelopmental disorder primarily affecting girls. The REVEAL Phase 1/2 clinical trial represents a significant advancement in the quest […]